Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.

by Adam Szulkin, Gustav Nilsonne, Filip Mundt, Agata M Wasik, Pega Souri, Anders Hjerpe, Katalin Dobra
Published 2013-01-01

Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma.

by Oluf Dimitri Røe, Adam Szulkin, Endre Anderssen, Arnar Flatberg, Helmut Sandeck, Tore Amundsen, Sten Even Erlandsen, Katalin Dobra, Stein Harald Sundstrøm
Published 2012-01-01